Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study. [electronic resource] by
- Casal Rubio, J
- Fírvida-Pérez, J L
- Lázaro-Quintela, M
- Barón-Duarte, F J
- Alonso-Jáudenes, G
- Santomé, L
- Afonso-Afonso, F J
- Amenedo, M
- Huidobro, G
- Campos-Balea, B
- López-Vázquez, M D
- Vázquez, S
Producer: 20140710
In:
Cancer chemotherapy and pharmacology vol. 73
Availability: No items available.
|